PubMed COVID-19 Clinical Care
11731 - 11740 of 44979 results found
Magnitude and Duration of Serum Neutralizing Antibody Titers Induced by a Third mRNA COVID-19 Vaccination against Omicron BA.1 in Older Individuals
Description
CONCLUSION: A third COVID-19 mRNA vaccine dose restored waning NAb titers against Omicron BA.1. Our findings support a third-dose vaccination program to prevent the waning of humoral immunity to SARS-CoV-2.
Erratum to "A case of de novo seronegative inflammatory oligoarthritis associated with COVID-19 infection" Clinical Immunology Communications 2 (2022) 159-161/
Description
[This corrects the article DOI: 10.1016/j.clicom.2022.10.001.].
Early Serial Echocardiographic and Ultrasonographic Findings in Critically Ill Patients With COVID-19
Description
BACKGROUND: Cardiac function of critically ill patients with COVID-19 generally has been reported from clinically obtained data. Echocardiographic deformation imaging can identify ventricular dysfunction missed by traditional echocardiographic
Evolutionary arms race between SARS-CoV-2 and interferon signaling via dynamic interaction with autophagy
Description
SARS-CoV-2 emerged, and is evolving to efficiently infect humans worldwide. SARS-CoV-2 evades early innate recognition, interferon signaling activated only in bystander cells. This balance of innate activation and viral evasion has important
Full-spike deep mutational scanning helps predict the evolutionary success of SARS-CoV-2 clades
Description
SARS-CoV-2 variants acquire mutations in spike that promote immune evasion and impact other properties that contribute to viral fitness such as ACE2 receptor binding and cell entry. Knowledge of how mutations affect these spike phenotypes can provide
SARS-CoV-2 antibody determination in a vaccinated and recovered cohort in Austria
Description
Since December 2019 the world has been dealing with a severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) pandemic. The first SARS-CoV-2 vaccine was made available in Europe at the end of 2020. 202 volunteers from the vicinity of the
Early combination therapy of COVID-19 in high-risk patients
Description
CONCLUSION: Early combination treatment of COVID-19 effectively prevented prolonged viral shedding in 85.6% of cases. Considering the rapid viral clearance rates and low toxicity, individualized dual therapy approaches may be beneficial in high-risk
Providing capacity in glaucoma care using trained and accredited optometrists: A qualitative evaluation
Description
CONCLUSION: Success in developing glaucoma services with optometrists and other health professionals is reliant on multi-stakeholder input, investment in technology and training, inter-professional respect and appropriate time and funding to set up
Explaining COVID-19 related mortality disparities in American Indians and Alaska Natives
Description
American Indian and Alaska Native (AI/AN) individuals are more likely to die with COVID-19 than other groups, but there is limited empirical evidence to explain the cause of this inequity. The objective of this study was to determine whether medical
